ZYME
Zymeworks Presents Preclinical Data on ZW1528 at the American Thoracic Society International Conference
Monday, May 19, 2025 BiopharmaWatch Research 1 min read Key Takeaway: Zymeworks Presents Preclinical Data on ZW1528 at the American Thoracic Society International Conference
Price reaction · baseline $11.71 (2025-05-16 close) · 2 other ZYME headline(s) in the window, move may be shared
BiopharmaWatch Analysis
From our catalyst data and publicly available data · not financial adviceBest trade, last catalyst
+23%
120-day peak, hindsight
Typical move
5.4%
average across 7 past catalysts
Cash runway
~35 mo
Minimal dilution risk
Lead asset
ZW49
Phase 1 · HER2-expressing Cancers
Full Press Release Details
Zymeworks Presents Preclinical Data on ZW1528 at the American Thoracic Society International Conference.